Skip to main content
Premium Trial:

Request an Annual Quote

Spectrum Solutions, UCLA Partner to Study Saliva-Based Early-Stage Lung Cancer Detection

NEW YORK – Spectrum Solutions on Wednesday announced a sponsored research study with the University of California, Los Angeles to explore the use of saliva for early-stage lung cancer detection. The group aims to validate saliva tumor-specific circulating tumor DNA (ctDNA) detection sensitivity and positive agreement against tissue biopsy-based genotyping.

As part of the study led by David Wong, professor of oral biology at the UCLA School of Dentistry, the researchers will collect, preserve, and transport saliva for DNA testing using Spectrum's saliva collection system.

Wong and his team will use next-generation sequencing to compare saliva and plasma samples from 50 non-small cell lung cancer patients to identify ultra-short ctDNA in saliva. The team will also use special extraction methods to improve the overall sensitivity of current liquid biopsy methods.

Spectrum is providing funding for the study and will further support development of clinical methods and additional technical innovations.

"Saliva-based liquid biopsy ctDNA detection can be used to not only provide an accurate cancer diagnosis, but additionally track the actionable mutations, monitor a response to treatments, and assess the emergence of drug resistance," Wong said in a statement. "This study's non-invasive use of saliva for the analysis of ctDNA will prove to overcome current limitations, provide procedures that improve detection sensitivity, and offer significant clinical impact on early detection, risk assessment, screening, diagnosis, and personalized [and] precision medicine."

Financial details of the agreement were not disclosed.

"We are proud to sponsor Dr. Wong and UCLA in this exciting research project to unlock and harness the potential of saliva as a primary diagnostic resource to combat and improve the lives and wellbeing of people around the world," Stephen Fanning, president and CEO of Spectrum, said in a statement.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.